keyword
https://read.qxmd.com/read/38634821/evaluation-of-tumorigenic-properties-of-mda-mb-231-cancer-stem-cells-cocultured-with-telocytes-and-telocyte-derived-mitochondria-following-mir-146a-inhibition
#1
JOURNAL ARTICLE
Sena Babadag, Özlem Altundag-Erdogan, Yeliz Z Akkaya-Ulum, Betül Çelebi-Saltik
Telocytes have some cytoplasmic extensions called telopodes, which are thought to play a role in mitochondrial transfer in intercellular communication. Besides, it is hypothesized that telocytes establish cell membrane-mediated connections with breast cancer cells in coculture and may contribute to the survival of neoplastic cell clusters together with other stromal cells. The aim of this study is to investigate the contribution of telocytes and telocyte-derived mitochondria, which have also been identified in breast tumors, to the tumor development of breast cancer stem cells (CSCs) via miR-146a-5p...
April 18, 2024: DNA and Cell Biology
https://read.qxmd.com/read/38633862/the-impact-of-ribosome-biogenesis-in-cancer-from-proliferation-to-metastasis
#2
JOURNAL ARTICLE
Sseu-Pei Hwang, Catherine Denicourt
The dysregulation of ribosome biogenesis is a hallmark of cancer, facilitating the adaptation to altered translational demands essential for various aspects of tumor progression. This review explores the intricate interplay between ribosome biogenesis and cancer development, highlighting dynamic regulation orchestrated by key oncogenic signaling pathways. Recent studies reveal the multifaceted roles of ribosomes, extending beyond protein factories to include regulatory functions in mRNA translation. Dysregulated ribosome biogenesis not only hampers precise control of global protein production and proliferation but also influences processes such as the maintenance of stem cell-like properties and epithelial-mesenchymal transition, contributing to cancer progression...
June 2024: NAR cancer
https://read.qxmd.com/read/38632238/tak1-inhibition-leads-to-ripk1-dependent-apoptosis-in-immune-activated-cancers
#3
JOURNAL ARTICLE
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
Poor survival and lack of treatment response in glioblastoma (GBM) is attributed to the persistence of glioma stem cells (GSCs). To identify novel therapeutic approaches, we performed CRISPR/Cas9 knockout screens and discovered TGFβ activated kinase (TAK1) as a selective survival factor in a significant fraction of GSCs. Loss of TAK1 kinase activity results in RIPK1-dependent apoptosis via Caspase-8/FADD complex activation, dependent on autocrine TNFα ligand production and constitutive TNFR signaling...
April 17, 2024: Cell Death & Disease
https://read.qxmd.com/read/38629370/unlocking-the-potential-of-induced-pluripotent-stem-cells-in-revolutionizing-cancer-therapy
#4
JOURNAL ARTICLE
Amrita Mondal, Ankita Talukdar, Rizwanul Haque
Induced Pluripotent Stem Cells (iPSCs) are among the top versatile implements of biomedical research. Stem cell science has made strides over the past few years, emerging as a new opportunity to treat cancer, and many such continuous initiatives have been made into clinical trials. As the global mortality rate is too high despite the effectiveness of prevalent cancer therapies, this review explores the potential of iPSC in different aspects of cancer-related areas. The preparation of iPSCs, including their derivation from cancer stem cells, was covered after establishing the intricacy of current cancer treatments...
April 15, 2024: Current Stem Cell Research & Therapy
https://read.qxmd.com/read/38628720/msln-induced-emt-cancer-stem-cell-traits-and-chemotherapy-resistance-of-pancreatic-cancer-cells
#5
JOURNAL ARTICLE
Jili Hu, Jia Wang, Xu Guo, Qing Fan, Xinming Li, Kai Li, Zhuoyin Wang, Shuntao Liang, Buhe Amin, Nengwei Zhang, Chaowen Chen, Bin Zhu
Chemoresistance is one of the main reasons for poor prognosis of pancreatic cancer. The effects of mesothelin (MSLN) on chemoresistance in pancreatic cancer are still unclear. We aim to investigate potential roles of MSLN in chemoresistance and its relationship with proliferation, epithelial-mesenchymal transition (EMT) and cancer stemness of pancreatic cancer cells. Human pancreatic cancer cell lines ASPC-1 and Mia PaCa-2 with high and low expression of MSLN, respectively, were selected. The ASPC-1 with MSLN knockout (KO) and Mia PaCa-2 of MSLN overexpression (OE) were generated...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38622439/crosstalk-between-lipid-metabolism-and-emt-emerging-mechanisms-and-cancer-therapy
#6
REVIEW
Zaheer Ud Din, Bai Cui, Cenxin Wang, Xiaoyu Zhang, Arshad Mehmood, Fei Peng, Quentin Liu
Lipids are the key component of all membranes composed of a variety of molecules that transduce intracellular signaling and provide energy to the cells in the absence of nutrients. Alteration in lipid metabolism is a major factor for cancer heterogeneity and a newly identified cancer hallmark. Reprogramming of lipid metabolism affects the diverse cancer phenotypes, especially epithelial-mesenchymal transition (EMT). EMT activation is considered to be an essential step for tumor metastasis, which exhibits a crucial role in the biological processes including development, wound healing, and stem cell maintenance, and has been widely reported to contribute pathologically to cancer progression...
April 15, 2024: Molecular and Cellular Biochemistry
https://read.qxmd.com/read/38617457/myocardial-metastasis-from-zeb1-and-twist-positive-spindle-cell-carcinoma-of-the-esophagus-a-case-report
#7
Yoshihiro Shibata, Hirofumi Ohmura, Kazuki Komatsu, Kosuke Sagara, Atsuji Matsuyama, Ryuji Nakano, Eishi Baba
BACKGROUND: Metastatic cardiac tumors are known to occur more frequently than primary cardiac tumors, however, they often remain asymptomatic and are commonly discovered on autopsy. Malignant tumors with a relatively high frequency of cardiac metastasis include mesothelioma, melanoma, lung cancer, and breast cancer, whereas reports of esophageal cancer with cardiac metastasis are rare. CASE SUMMARY: The case of a 60-year-old man who complained of dysphagia is presented...
March 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38615873/recent-strategies-to-overcome-breast-cancer-resistance
#8
REVIEW
Muhammad Muzamil Khan, Satya Siva Kishan Yalamarty, Bharat Ashok Rajmalani, Nina Filipczak, Vladimir P Torchilin
Breast cancer is potentially a lethal disease and a leading cause of death in women. Chemotherapy and radiotherapy are the most frequently used treatment options. Drug resistance in advanced breast cancer limits the therapeutic output of treatment. The leading cause of resistance in breast cancer is endocrine and hormonal imbalance, particularly in triple negative and HER2 positive breast cancers. The efflux of drugs due to p-gp's activity is another leading cause of resistance. Breast cancer resistant protein also contributes significantly...
April 12, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38614376/alternative-splicing-in-emt-and-tgf-%C3%AE-signaling-during-cancer-progression
#9
REVIEW
Ying E Zhang, Christina H Stuelten
Epithelial to mesenchymal transition (EMT) is a physiological process during development where epithelial cells transform to acquire mesenchymal characteristics, which allows them to migrate and colonize secondary tissues. Many cellular signaling pathways and master transcriptional factors exert a myriad of controls to fine tune this vital process to meet various developmental and physiological needs. Adding to the complexity of this network are post-transcriptional and post-translational regulations. Among them, alternative splicing has been shown to play important roles to drive EMT-associated phenotypic changes, including actin cytoskeleton remodeling, cell-cell junction changes, cell motility and invasiveness...
April 11, 2024: Seminars in Cancer Biology
https://read.qxmd.com/read/38613627/current-perspectives-and-progress-in-preoperative-portal-vein-embolization-with-stem-cell-augmentation-pvesa
#10
REVIEW
Allan John R Barcena, Tyler C Owens, Sophie Melancon, Isias Workeneh, Hop S Tran Cao, Jean-Nicolas Vauthey, Steven Y Huang
Portal vein embolization with stem cell augmentation (PVESA) is an emerging approach for enhancing the growth of the liver segment that will remain after surgery (i.e., future liver remnant, FLR) in patients with liver cancer. Conventional portal vein embolization (PVE) aims to induce preoperative FLR growth, but it has a risk of failure in patients with underlying liver dysfunction and comorbid illnesses. PVESA combines PVE with stem cell therapy to potentially improve FLR size and function more effectively and efficiently...
April 13, 2024: Stem cell reviews and reports
https://read.qxmd.com/read/38612653/a-stem-like-patient-derived-ovarian-cancer-model-of-platinum-resistance-reveals-dissociation-of-stemness-and-resistance
#11
JOURNAL ARTICLE
Tise Suzuki, Ashlyn Conant, Yeonkyu Jung, Ryan Bax, Ashley Antonissen, Wanqiu Chen, Gary Yu, Yevgeniya J Ioffe, Charles Wang, Juli J Unternaehrer
To understand chemoresistance in the context of cancer stem cells (CSC), a cisplatin resistance model was developed using a high-grade serous ovarian cancer patient-derived, cisplatin-sensitive sample, PDX4. As a molecular subtype-specific stem-like cell line, PDX4 was selected for its representative features, including its histopathological and BRCA2 mutation status, and exposed to cisplatin in vitro. In the cisplatin-resistant cells, transcriptomics were carried out, and cell morphology, protein expression, and functional status were characterized...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612457/enhanced-therapeutic-potential-of-hybrid-exosomes-loaded-with-paclitaxel-for-cancer-therapy
#12
JOURNAL ARTICLE
Xuan Wang, Dongdong Li, Gaotian Li, Jinda Chen, Yi Yang, Lijun Bian, Jingying Zhou, Yongge Wu, Yan Chen
The advancement of exosome studies has positioned engineered exosomes as crucial biomaterials for the development of advanced drug delivery systems. This study focuses on developing a hybrid exosome system by fusing mesenchymal stem cells (MSCs) exosomes with folate-targeted liposomes. The aim was to improve the drug loading capacity and target modification of exosome nanocarriers for delivering the first-line chemotherapy drug paclitaxel (PTX) and its effectiveness was assessed through cellular uptake studies to evaluate its ability to deliver drugs to tumor cells in vitro...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38607066/silencing-the-mitochondrial-gatekeeper-vdac1-as-a-potential-treatment-for-bladder-cancer
#13
JOURNAL ARTICLE
Belal Alhozeel, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, Manikandan Santhanam, Varda Shoshan-Barmatz
The strategy for treating bladder cancer (BC) depends on whether there is muscle invasion or not, with the latter mostly treated with intravesical therapy, such as with bacillus Calmette-Guérin (BCG). However, BCG treatment is unsuccessful in 70% of patients, who are then subjected to radical cystectomy. Although immune-checkpoint inhibitors have been approved as a second-line therapy for a subset of BC patients, these have failed to meet primary endpoints in clinical trials. Thus, it is crucial to find a new treatment...
April 4, 2024: Cells
https://read.qxmd.com/read/38607003/hippo-signaling-at-the-hallmarks-of-cancer-and-drug-resistance
#14
REVIEW
Ramesh Kumar, Wanjin Hong
Originally identified in Drosophila melanogaster in 1995, the Hippo signaling pathway plays a pivotal role in organ size control and tumor suppression by inhibiting proliferation and promoting apoptosis. Large tumor suppressors 1 and 2 (LATS1/2) directly phosphorylate the Yki orthologs YAP (yes-associated protein) and its paralog TAZ (also known as WW domain-containing transcription regulator 1 [WWTR1]), thereby inhibiting their nuclear localization and pairing with transcriptional coactivators TEAD1-4. Earnest efforts from many research laboratories have established the role of mis-regulated Hippo signaling in tumorigenesis, epithelial mesenchymal transition (EMT), oncogenic stemness, and, more recently, development of drug resistances...
March 22, 2024: Cells
https://read.qxmd.com/read/38606999/phenotypic-heterogeneity-of-cancer-associated-fibroblasts-in-cervical-cancer-progression-fap-as-a-central-activation-marker
#15
JOURNAL ARTICLE
Lesly Jazmin Bueno-Urquiza, Marisol Godínez-Rubí, Julio César Villegas-Pineda, Alejandra Natali Vega-Magaña, Luis Felipe Jave-Suárez, Ana Graciela Puebla-Mora, Gloria Estefanía Aguirre-Sandoval, María Guadalupe Martínez-Silva, Adrián Ramírez-de-Arellano, Ana Laura Pereira-Suárez
Cervical cancer (CC) is the fourth leading cancer among women and is one of the principal gynecological malignancies. In the tumor microenvironment, cancer-associated fibroblasts (CAFs) play a crucial role during malignant progression, exhibiting a variety of heterogeneous phenotypes. CAFs express phenotypic markers like fibroblast activation protein (FAP), vimentin, S100A4, α-smooth muscle actin (αSMA), and functional markers such as MMP9. This study aimed to evaluate the protein expression of vimentin, S100A4, αSMA, FAP, and MMP9 in mesenchymal stem cells (MSC)-CAF cells, as well as in cervical cancer samples...
March 22, 2024: Cells
https://read.qxmd.com/read/38606479/prostate-cancer-associated-transcript-6-pcat6-promotes-epithelial-mesenchymal-transition-and-stemness-and-worsens-prognosis-in-patients-with-colorectal-cancer
#16
JOURNAL ARTICLE
Xun Sun, Yitao Yuan, Suyao Li, Lu Gan, Midie Xu, Qingguo Li, Mengling Liu, Keshu Hu, Ke Nan, Jiayu Zhang, Yu Dong, Yufu Lin, Xiuping Zhang, Pengcong Hou, Tianshu Liu
Approximately 20% of colorectal cancer (CRC) patients are first diagnosed with metastatic colorectal cancer (mCRC) because they develop symptoms at an advanced stage. Despite advancements in treatment, patients with metastatic disease still experience inferior survival rates. Our objective is to investigate the association between long noncoding RNAs (lncRNAs) and prognosis and to explore their role in mCRC. In this study, we find that elevated expression of PCAT6 is independently linked to unfavourable survival outcomes in The Cancer Genome Atlas (TCGA) data, and this finding is further confirmed in CRC samples obtained from Fudan University Shanghai Cancer Center...
April 11, 2024: Acta Biochimica et Biophysica Sinica
https://read.qxmd.com/read/38602594/cancer-associated-fibroblasts-a-versatile-mediator-in-tumor-progression-metastasis-and-targeted-therapy
#17
REVIEW
Tianchen Guo, Junfen Xu
Tumor microenvironment (TME) has been demonstrated to play a significant role in tumor initiation, progression, and metastasis. Cancer-associated fibroblasts (CAFs) are the major component of TME and exhibit heterogeneous properties in their communication with tumor cells. This heterogeneity of CAFs can be attributed to various origins, including quiescent fibroblasts, mesenchymal stem cells (MSCs), adipocytes, pericytes, endothelial cells, and mesothelial cells. Moreover, single-cell RNA sequencing has identified diverse phenotypes of CAFs, with myofibroblastic CAFs (myCAFs) and inflammatory CAFs (iCAFs) being the most acknowledged, alongside newly discovered subtypes like antigen-presenting CAFs (apCAFs)...
April 11, 2024: Cancer Metastasis Reviews
https://read.qxmd.com/read/38601284/tumor-derived-mesenchymal-progenitor-cell-related-genes-in-the-regulation-of-breast-cancer-proliferation
#18
JOURNAL ARTICLE
Yizhu Chen, Li Zhu, Yiming Wang, Jia Hu, Hao Zhang, Jingjin Zhu, Wenye Gong, Xiaohan Liu, Fengjun Xiao, Xiru Li
BACKGROUND: Breast cancer (BC) is one of the most common malignancies worldwide, and its development is affected in various ways by the tumor microenvironment (TME). Tumor-derived mesenchymal progenitor cells (MPCs), as the most important components of the TME, participate in the proliferation and metastasis of BC in several ways. In this study, we aimed to characterize the genes associated with tumor-derived MPCs and determine their effects on BC cells. METHODS: Tumor-derived MPCs and normal breast tissue-derived mesenchymal stem cells (MSCs) were isolated from tissues specimens of patients with BC...
March 27, 2024: Gland Surgery
https://read.qxmd.com/read/38600165/nrf2-activation-by-cysteine-as-a-survival-mechanism-for-triple-negative-breast-cancer-cells
#19
JOURNAL ARTICLE
Laura Bottoni, Alberto Minetti, Giulia Realini, Elena Pio, Daniela Giustarini, Ranieri Rossi, Chiara Rocchio, Lorenzo Franci, Laura Salvini, Orazio Catona, Romina D'Aurizio, Mahdi Rasa, Emanuele Giurisato, Francesco Neri, Maurizio Orlandini, Mario Chiariello, Federico Galvagni
Triple-negative breast cancer (TNBC) is a very aggressive and heterogeneous group of tumors. In order to develop effective therapeutic strategies, it is therefore essential to identify the subtype-specific molecular mechanisms underlying disease progression and resistance to chemotherapy. TNBC cells are highly dependent on exogenous cystine, provided by overexpression of the cystine/glutamate antiporter SLC7A11/xCT, to fuel glutathione synthesis and promote an oxidative stress response consistent with their high metabolic demands...
April 10, 2024: Oncogene
https://read.qxmd.com/read/38598065/gastric-cancer-mesenchymal-stem-cells-trigger-endothelial-cell-functional-changes-to-promote-cancer-progression
#20
JOURNAL ARTICLE
Linjing Cui, Ting Liu, Chao Huang, Fumeng Yang, Liqi Luo, Li Sun, Yuanyuan Zhao, Deqiang Wang, Mei Wang, Yong Ji, Wei Zhu
Our previous studies have highlighted the pivotal role of gastric cancer mesenchymal stem cells (GCMSCs) in tumor initiation, progression, and metastasis. In parallel, it is well-documented that endothelial cells (ECs) undergo functional alterations in response to challenging tumor microenvironment. This study aims to elucidate whether functional changes in ECs might be induced by GCMSCs and thus influence cancer progression. Cell proliferation was assessed through CCK-8 and colony formation assays, while cell migration and invasion capabilities were evaluated by wound-healing and Transwell assays...
April 10, 2024: Stem cell reviews and reports
keyword
keyword
43351
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.